# Environmental Assessment: Questions and Answers Regarding Drugs With Estrogenic, Androgenic, or Thyroid Activity - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/environmental-assessment-questions-and-answers-regarding-drugs-with-estrogenic-androgenic-or-thyroid-activity/4f1defd1-fc55-4b85-a9ba-279954bdd658

> FDA guidance document: Environmental Assessment: Questions and Answers Regarding Drugs With Estrogenic, Androgenic, or Thyroid Activity. Issue date: March 04, 2016. Get complete insights and analysis.

---

## Details

- Title: Environmental Assessment: Questions and Answers Regarding Drugs With Estrogenic, Androgenic, or Thyroid Activity
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2016-03-04
- Last Changed: 2019-06-03

## Related Documents

- [Liposome Drug Products: Chemistry, Manufacturing, and Controls; Human Pharmacokinetics and Bioavailability; and Labeling Documentation](https://www.globalkeysolutions.net/guidances/guidance-document/liposome-drug-products-chemistry-manufacturing-and-controls-human-pharmacokinetics-and-bioavailability-and-labeling-documentation/b27b2c8a-0cb8-4775-aba0-e2a39c06fd48)
- [Botanical Drug Development: Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/botanical-drug-development-guidance-for-industry/bec78068-96c3-424e-b070-7b4ecfcfc8bf)
- [E2C(R2) Periodic Benefit-Risk Evaluation Report – Questions and Answers](https://www.globalkeysolutions.net/guidances/guidance-document/e2cr2-periodic-benefit-risk-evaluation-report-questions-and-answers/9735c0c5-468e-4e9b-a4c9-a7bad1eb9d94)